Forum · Medicine · Story discussion
'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment
(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC)…
1.6 hours ago — MedPage Today · Read the original
Peer reviews (0)
Comments (0)
No comments yet. Start the discussion.
Loading sign-in…